- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity –
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
Seeking Alpha / 3 hours ago 1 Views
Seeking Alpha / 3 hours ago 1 Views
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity –
Comments